Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.

Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.

Item
http://www.wikidata.org/entity/Q33569429
Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performanceAdvances in device and formulation technologies for pulmonary drug delivery.Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and RifampicinEffect of device design on the aerosolization of a carrier-based dry powder inhaler--a case study on Aerolizer(®) Foradile (®).Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.Functionalised particles using dry powder coating in pharmaceutical drug delivery: promises and challenges.A review of co-milling techniques for the production of high dose dry powder inhaler formulation.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunitiesThe Effects of Relative Humidity on the Flowability and Dispersion Performance of Lactose MixturesEngineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.
P2860

Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.

Item
http://www.wikidata.org/entity/Q33569429
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Understanding the influence of ...... pharmaceutical model powders.
@ast
Understanding the influence of ...... pharmaceutical model powders.
@en
Understanding the influence of ...... pharmaceutical model powders.
@nl
type
label
Understanding the influence of ...... pharmaceutical model powders.
@ast
Understanding the influence of ...... pharmaceutical model powders.
@en
Understanding the influence of ...... pharmaceutical model powders.
@nl
prefLabel
Understanding the influence of ...... pharmaceutical model powders.
@ast
Understanding the influence of ...... pharmaceutical model powders.
@en
Understanding the influence of ...... pharmaceutical model powders.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Understanding the influence of ...... pharmaceutical model powders.
@en
P2093
P304
P31
P356
10.1016/J.EJPS.2010.04.012
P407
P433
P478
P50
P577
P698